GH RESEARCH PLC Share Price Today: Live Updates & Key Insights

GH RESEARCH PLC share price today is $27.29, up -1.27%. The stock opened at $27.0625 against the previous close of $27.63, with an intraday high of $28 and low of $26.75.

GH RESEARCH PLC Share Price Chart

GH RESEARCH PLC

us-stock
To Invest in {{usstockname}}
us-stock

GH RESEARCH PLC Share Price Performance

$27.29 -0.0127(-1.27%) GHRS at 27 Jul 2026 03:17 PM Biotechnology
Lowest Today 26.75
Highest Today 28
Today’s Open 27.0625
Prev. Close 27.63
52 Week High 31.00
52 Week Low 11.32
Day’s Range: Low 26.75 High 28
52-Week Range: Low 11.32 High 31.00
1 day return -
1 Week return -0.69
1 month return -3.56
3 month return +39.83
6 month return +64.12
1 year return +83.35
3 year return +118.48
5 year return +61.59
10 year return -

GH RESEARCH PLC Institutional Holdings

Lynx1 Capital Management, LP 15.69

Bvf Inc 12.61

RA Capital Management, LLC 11.19

RTW INVESTMENTS, LLC 8.65

FMR Inc 7.49

Fidelity Growth Compy Commingled Pl S 4.22

Fidelity Growth Company Fund 2.64

venBio Select Advisor LLC 2.62

The Toronto-Dominion Bank 2.04

Millennium Management LLC 1.37

Jefferies Financial Group Inc 1.04

Fidelity Growth Company K6 0.86

5AM Venture Management, LLC 0.83

Fidelity Series Growth Company 0.67

BlackRock Inc 0.66

UBS Group AG 0.60

iShares Biotechnology ETF 0.51

Squadron Capital Management LLC 0.47

Foresite Capital Management VI LLC 0.46

BOOTHBAY FUND MANAGEMENT, LLC 0.41

CenterBook Partners LP 0.32

HighVista Strategies LLC 0.31

Fidelity Select Biotechnology 0.13

Marshall Wace Asset Management Ltd 0.13

Occam Crest Management L.P. 0.12

AdvisorShares Psychedelics ETF 0.10

Trexquant Investment LP 0.10

iShares MSCI Ireland ETF 0.08

iShares Nasdaq US Biotech ETF USD Acc 0.08

Fidelity Nasdaq Composite Index 0.06

TEQ - Disruptive Technologies - I-II 0.05

Arrow Long/Short Alt Fd F 0.04

Arrow Opportunities Alternative Series F 0.04

A4Investments SICAV SIF ACCI IlanaA2EURH 0.04

Virtus LifeSci Biotech Clinical Trls ETF 0.02

State Street® SPDR® S&P® Intl Sm Cp ETF 0.02

Exemplar Performance Series F 0.02

China Universal NASDAQ Bio-Tch ETF(QDII) 0.01

Northern Small Cap Core I 0.01

BSF Systematic US Eq Abs Ret A2 USD 0.01

GH RESEARCH PLC Market Status

Strong Buy: 5

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 0

GH RESEARCH PLC Fundamentals

Market Cap 1895.66 M

PB Ratio 7.4085

PE Ratio 0.0

Enterprise Value 1693.95 M

Total Assets 288.23 M

Volume 163893

GH RESEARCH PLC Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:-315000 -0.3M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-35587000 -35.6M, FY22:-7135000 -7.1M, FY21:-9211000 -9.2M, FY20:-446000 -0.4M, FY19:-310000 -0.3M

Quarterly Revenue Q1/2026:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M

Quarterly Profit Q1/2026:-90999 -0.1M, Q3/2025:-89000 -0.1M, Q2/2025:-82000 -0.1M, Q1/2025:-76000 -0.1M, Q3/2024:null 0.0M

Quarterly Net worth Q1/2026:-18966999 -19.0M, Q3/2025:-14020000 -14.0M, Q2/2025:-9289000 -9.3M, Q1/2025:-10812000 -10.8M, Q3/2024:-12114000 -12.1M

About GH RESEARCH PLC & investment objective

Company Information GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States. The company's lead product candidate is GH001, an inhalable mebufotenin product candidate that is in Phase 2b clinical trial for treating patients with treatment-resistant depression and in Phase 2a clinical trials for treating bipolar II disorder and postpartum depression. It also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland.

Organisation Biotechnology

Employees 73

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

GH RESEARCH PLC FAQs

What is the share price of GH RESEARCH PLC today?

The current share price of GH RESEARCH PLC is $27.29.

Can I buy GH RESEARCH PLC shares in India?

Yes, Indian investors can buy GH RESEARCH PLC shares by opening an international trading and demat account with Motilal Oswal.

How to buy GH RESEARCH PLC shares in India?

You can easily invest in GH RESEARCH PLC shares from India by:

Can I buy fractional shares of GH RESEARCH PLC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of GH RESEARCH PLC?

GH RESEARCH PLC has a market cap of $1895.66 M.

In which sector does GH RESEARCH PLC belong?

GH RESEARCH PLC operates in the Biotechnology sector.

What documents are required to invest in GH RESEARCH PLC stocks?

To invest, you typically need:

What is the PE and PB ratio of GH RESEARCH PLC?

The PE ratio of GH RESEARCH PLC is N/A and the PB ratio is 7.41.